Corrigendum: 17β-Estradiol inhibits MMP-9 and SUR1/TrpM4 expression and activation and thereby attenuates BSCB disruption/hemorrhage after spinal cord injury in male rats (Endocrinology (2015) 156:5 (1838-1850) DOI: 10.1210/en.2014-1832);17β-estradiol inhibits MMP-9 and SUR1/TrpM4 expression and activation and thereby attenuates BSCB disruption/hemorrhage after spinal cord injury in male rats

Endocrinology

Volumn 156, Issue 5, 2015, Pages 1838-1850

  Lee, Jee Y ^a   Choi, Hae Y ^a   Na, Won H ^b   Ju, Bong G ^b   Yune, Tae Y ^a  

^a Kyung Hee University Hospital   (South Korea)

^b Sogang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL2 CHEMOKINE; CYCLOOXYGENASE 2; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; GELATINASE A; GELATINASE B; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUROPROTECTIVE AGENT; OCCLUDIN; PROTEIN ZO1; SULFONYLUREA RECEPTOR 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL M4; TUMOR NECROSIS FACTOR ALPHA; ABCC8 PROTEIN, RAT; ESTROGEN RECEPTOR ANTAGONIST; MMP9 PROTEIN, RAT; SULFONYLUREA RECEPTOR; TRANSIENT RECEPTOR POTENTIAL CHANNEL M; TRPM4 PROTEIN, RAT;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BLOOD SPINAL CORD BARRIER; CONTROLLED STUDY; CONTUSION; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INHIBITION; MACROPHAGE; MALE; MYELITIS; NEUROPROTECTION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; SPINAL CORD HEMORRHAGE; SPINAL CORD INJURY; UPREGULATION; ANALOGS AND DERIVATIVES; ANIMAL; APOPTOSIS; BLEEDING; BLOOD BRAIN BARRIER; CAPILLARY PERMEABILITY; DRUG EFFECTS; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; BLOOD-BRAIN BARRIER; CAPILLARY PERMEABILITY; DOWN-REGULATION; ESTRADIOL; ESTROGEN RECEPTOR ANTAGONISTS; HEMORRHAGE; MALE; MATRIX METALLOPROTEINASE 9; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD INJURIES; SULFONYLUREA RECEPTORS; TRPM CATION CHANNELS;

EID: 84929001102     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2018-00528     Document Type: Erratum

References (60)

1. Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev. 2005;57:173-185.
2. Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron. 2008;57:178-201.
3. Abbott NJ, Rönnbäck L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci. 2006;7:41-53.
4. Noble LJ, Donovan F, Igarashi T, Goussev S, Werb Z. Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events. J Neurosci. 2002;22:7526-7535.
5. Xu J, Kim GM, Ahmed SH, et al. Glucocorticoid receptor-mediated suppression of activator protein-1 activation and matrix metalloproteinase expression after spinal cord injury. J Neurosci. 2001;21: 92-97.
6. Gerzanich V, Woo SK, Vennekens R, et al. De novo expression of Trpm4 initiates secondary hemorrhage in spinal cord injury. Nat Med. 2009;15:185-191.
7. Rosenberg GA, Estrada EY, Dencoff JE. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke. 1998;29:2189-2195.
8. Asahi M, Wang X, Mori T, et al. Effects of matrix metalloproteinase- 9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci. 2001; 21:7724-7732.
9. Simard JM, Tsymbalyuk O, Ivanov A, et al. Endothelial sulfonylurea receptor 1-regulated NC Ca-ATP channels mediate progressive hemorrhagic necrosis following spinal cord injury. J Clin Invest. 2007;117:2105-2113.
10. Simard JM, Woo SK, Norenberg MD, et al. Brief suppression of Abcc8 prevents autodestruction of spinal cord after trauma. Sci Transl Med. 2010;2:28ra29.
11. Bedard P, Langelier P, Villeneuve A. Oestrogens and extrapyramidal system. Lancet. 1977;2:1367-1368.
12. Tang MX, Jacobs D, Stern Y, et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 1996; 348:429-432.
13. Soustiel JF, Palzur E, Nevo O, Thaler I, Vlodavsky E. Neuroprotective anti-apoptosis effect of estrogens in traumatic brain injury. J Neurotrauma. 2005;22:345-352.
14. Garcia-Segura LM, Azcoitia I, DonCarlos LL. Neuroprotection by estradiol. Prog Neurobiol. 2001;63:29-60.
15. Yune TY, Kim SJ, Lee SM, et al. Systemic administration of 17β- estradiol reduces apoptotic cell death and improves functional recovery following traumatic spinal cord injury in rats. J Neurotrauma. 2004;21:293-306.
16. Yune TY, Park HG, Lee JY, Oh TH. Estrogen-induced Bcl-2 expression after spinal cord injury is mediated through phosphoinositide- 3-kinase/Akt-dependent CREB activation. J Neurotrauma. 2008;25:1121-1131.
17. Lee JY, Choi SY, OhTH, Yune TY. 17β-estradiol inhibits apoptotic cell death of oligodendrocytes by inhibiting RhoA-JNK3 activation after spinal cord injury. Endocrinology. 2012;153:3815-3827.
18. Chi OZ, Hunter C, Liu X, Weiss HR. Effects of 17β-estradiol on blood-brain barrier disruption during focal cerebral ischemia in younger and older rats. Horm Metab Res. 2006;38:377-381.
19. Li M, Zhang Z, Sun W, Koehler RC, Huang J. 17β-estradiol attenuates breakdown of blood-brain barrier and hemorrhagic transformation induced by tissue plasminogen activator in cerebral ischemia. Neurobiol Dis. 2011;44:277-283.
20. Liu R, Liu Q, He S, Simpkins JW, Yang SH. Combination therapy of 17β-estradiol and recombinant tissue plasminogen activator for experimental ischemic stroke. J Pharmacol Exp Ther. 2010;332: 1006-1012.
21. Tomás-Camardiel M, Venero JL, Herrera AJ, et al. Blood-brain barrier disruption highly induces aquaporin-4mRNAand protein in perivascular and parenchymal astrocytes: protective effect by estradiol treatment in ovariectomized animals. J Neurosci Res. 2005;80: 235-246.
22. Lee JY, Chung H, Yoo YS, et al. Inhibition of apoptotic cell death by ghrelin improves functional recovery after spinal cord injury. Endocrinology. 2010;151:3815-3826.
23. Lee JY, Kim HS, Choi HY, Oh TH, Ju BG, Yune TY. Valproic acid attenuates blood-spinal cord barrier disruption by inhibiting matrix metalloprotease-9 activity and improves functional recovery after spinal cord injury. J Neurochem. 2012;121:818-829.
24. Lee JY, Choi HY, Ahn HJ, Ju BG, Yune TY. Matrix metalloproteinase- 3 promotes early blood-spinal cord barrier disruption and hemorrhage and impairs long-term neurological recovery after spinal cord injury. Am J Pathol. 2014;184:2985-3000.
25. Lee JY, Kim HS, Choi HY, Oh TH, Yune TY. Fluoxetine inhibits matrix metalloprotease activation and prevents disruption of bloodspinal cord barrier after spinal cord injury. Brain. 2012;135:2375-2389.
26. Basso DM, Fisher LC, Anderson AJ, Jakeman LB, McTigue DM, Popovich PG. Basso mouse scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma. 2006;23:635-659.
27. Yune TY, Lee JY, Jung GY, et al. Minocycline alleviates death of oligodendrocytes by inhibiting pro-nerve growth factor production in microglia after spinal cord injury. J Neurosci. 2007;27:7751-7761.
28. Chi OZ, Hunter C, Liu X, Weiss HR. Effects of 17β-estradiol on blood-brain barrier disruption in focal ischemia during GABA(A) receptor inhibition. Horm Metab Res. 2005;37:209-213.
29. Mun-Bryce S, Rosenberg GA. Gelatinase B modulates selective opening of the blood-brain barrier during inflammation. Am J Physiol. 1998;274:R1203-R1211.
30. Mun-Bryce S, Rosenberg GA. Matrix metalloproteinases in cerebrovascular disease. J Cereb Blood Flow Metab. 1998;18:1163-1172.
31. Pineau I, Lacroix S. Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved. J Comp Neurol. 2007;500:267-285.
32. McTigue DM, Tani M, Krivacic K, et al. Selective chemokine mRNA accumulation in the rat spinal cord after contusion injury. J Neurosci Res. 1998;53:368-376.
33. Ghirnikar RS, Lee YL, Eng LF. Chemokine antagonist infusion promotes axonal sparing after spinal cord contusion injury in rat. J Neurosci Res. 2001;64:582-589.
34. Ousman SS, David S. MIP-1α, MCP-1, GM-CSF, and TNF-α control the immune cell response that mediates rapid phagocytosis of myelin from the adult mouse spinal cord. J Neurosci. 2001;21: 4649-4656.
35. Hawkins MB, Thomas P. The unusual binding properties of the third distinct teleost estrogen receptor subtype ER-1αa are accompanied by highly conserved amino acid changes in the ligand binding domain. Endocrinology. 2004;145:2968-2977.
36. Liu R, Wen Y, Perez E, et al. 17β-estradiol attenuates blood-brain barrier disruption induced by cerebral ischemia-reperfusion injury in female rats. Brain Res. 2005;1060:55-61.
37. de Castro RC Jr, Burns CL, McAdoo DJ, Romanic AM. Metalloproteinase increases in the injured rat spinal cord. Neuroreport. 2000;11:3551-3554.
38. Hsu JY, McKeon R, Goussev S, et al. Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury. J Neurosci. 2006;26:9841-9850.
39. Lee JY, Choi HY, Ahn H-J, Ju BG, Yune TY. Matrix metalloproteinase- 3 promotes early blood-spinal cord barrier disruption and hemorrhage and impairs long-term neurological recovery after spinal cord injury. Am J Pathol. 2014;184:2985-3000.
40. Bauer AT, Bürgers HF, Rabie T, Marti HH. Matrix metalloproteinase- 9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement. J Cereb Blood Flow Metab. 2010;30: 837-848.
41. Balentine JD, Spector M. Calcification of axons in experimental spinal cord trauma. Ann Neurol. 1977;2:520-523.
42. Kawata K, Morimoto T, Ohashi T, et al. [Experimental study of acute spinal cord injury: a histopathological study]. No Shinkei Geka. 1993;21:45-51.
43. Guo J, Li R, Zhao P, Cheng J. Effect of taurine in combination with electroacupuncture on neuronal damage following transient focal cerebral ischemia in rats. Acupunct Electrother Res. 2002;27:129-136.
44. Stirone C, Duckles SP, Krause DN. Multiple forms of estrogen receptor-α in cerebral blood vessels: regulation by estrogen. Am J Physiol Endocrinol Metab. 2003;284:E184-E192.
45. Odenlund M, Ekblad E, Nilsson BO. Stimulation of oestrogen receptor- expressing endothelial cells with oestrogen reduces proliferation of cocultured vascular smooth muscle cells. Clin Exp Pharmacol Physiol. 2008;35:245-248.
46. Razmara A, Sunday L, Stirone C, et al. Mitochondrial effects of estrogen are mediated by estrogen receptorβ in brain endothelial cells. J Pharmacol Exp Ther. 2008;325:782-790.
47. Guo J, Krause DN, Horne J, Weiss JH, Li X, Duckles SP. Estrogenreceptor- mediated protection of cerebral endothelial cell viability and mitochondrial function after ischemic insult in vitro. J Cereb Blood Flow Metab. 2010;30:545-554.
48. Hauben E, Mizrahi T, Agranov E, Schwartz M. Sexual dimorphism in the spontaneous recovery from spinal cord injury: a gender gap in beneficial autoimmunity? Eur J Neurosci. 2002;16:1731-1740.
49. Brown CM, Suzuki S, Jelks KA, Wise PM. Estradiol is a potent protective, restorative, and trophic factor after brain injury. Semin Reprod Med. 2009;27:240-249.
50. Stein B, Yang MX. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-κB and C/EBPβ. Mol Cell Biol. 1995;15:4971-4979.
51. Scafonas A, Reszka AA, Kimmel DB, et al. Agonist-like SERM effects on ER-1α-mediated repression of MMP1 promoter activity predict in vivo effects on bone and uterus. J Steroid Biochem Mol Biol. 2008;110:197-206.
52. Beischlag TV, Perdew GH. ER-1α-AHR-ARNT protein-protein interactions mediate estradiol-dependent transrepression of dioxininducible gene transcription. J Biol Chem. 2005;280:21607-21611.
53. Kanda N, Watanabe S. 17β-estradiol inhibits MCP-1 production in human keratinocytes. J Invest Dermatol. 2003;120:1058-1066.
54. Saijo K, Collier JG, Li AC, Katzenellenbogen JA, Glass CK. An ADIOL-ER-1α-CtBP transrepression pathway negatively regulates microglia-mediated inflammation. Cell. 2011;145:584-595.
55. Simard JM, Geng Z, Woo SK, et al. Glibenclamide reduces inflammation, vasogenic edema, and caspase-3 activation after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2009;29:317-330.
56. Patel AD, Gerzanich V, Geng Z, Simard JM. Glibenclamide reduces hippocampal injury and preserves rapid spatial learning in a model of traumatic brain injury. J Neuropathol Exp Neurol. 2010;69: 1177-1190.
57. Asl SZ, Khaksari M, Khachki AS, Shahrokhi N, Nourizade S. Contribution of estrogen receptors α and β in the brain response to traumatic brain injury. J Neurosurg. 2013;119:353-361.
58. Shin JA, Yang SJ, Jeong SI, Park HJ, Choi YH, Park EM. Activation of estrogen receptorβ reduces blood-brain barrier breakdown following ischemic injury. Neuroscience. 2013;235:165-173.
59. Alonso de Leciñana M, Egido JA. Estrogens as neuroprotectants against ischemic stroke. Cerebrovasc Dis. 2006;21(suppl 2):48-53.
60. Simpkins JW, Dykens JA. Mitochondrial mechanisms of estrogen neuroprotection. Brain Res Rev. 2008;57:421-430.